Antioxidant enzymes, such as superoxide dismutase 1 and 2, catalase, and heme oxygenase 1, are markedly upregulated in active demyelinating MS lesions compared to normal appearing white matter and white matter tissue from non-neurological control brains. This evidence concerns the gene SOD1 and myeloid sarcoma.